[EN] CONFORMATIONALLY CONSTRAINED PACLITAXEL ANALOGS AND THEIR USE AS ANTICANCER AND ANTI-ALZHEIMERS AGENTS<br/>[FR] ANALOGUES DE PACLITAXEL A CONTRAINTES CONFORMATIONNELLES ET LEUR UTILISATION EN TANT QU'AGENTS ANTICANCEREUX ET ANTI-ALZHEIMER
申请人:VIRGINIA TECH INTELL PROP
公开号:WO2005070414A1
公开(公告)日:2005-08-04
Constrained paclitaxel derivatives include a bridge extending from the C-3’ phenyl to either the C4 or -3 positions. Many of the constrained paclitaxel derivatives provide activity comparable or superior to the natural product paclitaxel.
Synthesis and Biological Evaluation of Novel Macrocyclic Paclitaxel Analogues
作者:Belhu B. Metaferia、Jeannine Hoch、Thomas E. Glass、Susan L. Bane、Sabarni K. Chatterjee、James P. Snyder、Ami Lakdawala、Ben Cornett、David G. I. Kingston
DOI:10.1021/ol016124d
日期:2001.8.9
[reaction: see text] This work describes the synthesis of two novelmacrocyclic taxoid constructs by ring-closing olefin metathesis (RCM) and their biological evaluation. Computational studies examine conformational profiles of 1 and 2 for their fit to the beta-tubulin binding site determined by electron crystallography. The results support the hypothesis that paclitaxel binds to microtubules in a